- Home
- ORLA vs PTGX Comparison
ORLA vs PTGX Comparison
Compare ORLA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- PTGX
- Stock Information
- Founded
- ORLA 2007
- PTGX 2006
- Country
- ORLA Canada
- PTGX United States
- Employees
- ORLA N/A
- PTGX N/A
- Industry
- ORLA Precious Metals
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ORLA Basic Materials
- PTGX Health Care
- Exchange
- ORLA Nasdaq
- PTGX Nasdaq
- Market Cap
- ORLA 3.1B
- PTGX 5.0B
- IPO Year
- ORLA N/A
- PTGX 2016
- Fundamental
- Price
- ORLA $10.69
- PTGX $83.89
- Analyst Decision
- ORLA Buy
- PTGX Strong Buy
- Analyst Count
- ORLA 1
- PTGX 9
- Target Price
- ORLA $27.00
- PTGX $86.22
- AVG Volume (30 Days)
- ORLA 2.7M
- PTGX 998.7K
- Earning Date
- ORLA 11-11-2025
- PTGX 11-06-2025
- Dividend Yield
- ORLA N/A
- PTGX N/A
- EPS Growth
- ORLA N/A
- PTGX N/A
- EPS
- ORLA 0.07
- PTGX 0.72
- Revenue
- ORLA $596,487,000.00
- PTGX $209,217,000.00
- Revenue This Year
- ORLA $182.00
- PTGX N/A
- Revenue Next Year
- ORLA $38.17
- PTGX $140.23
- P/E Ratio
- ORLA $144.01
- PTGX $115.56
- Revenue Growth
- ORLA 116.83
- PTGX N/A
- 52 Week Low
- ORLA $3.81
- PTGX $33.31
- 52 Week High
- ORLA $13.91
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- ORLA 50.85
- PTGX 68.79
- Support Level
- ORLA $9.45
- PTGX $76.70
- Resistance Level
- ORLA $10.57
- PTGX $80.43
- Average True Range (ATR)
- ORLA 0.46
- PTGX 2.82
- MACD
- ORLA -0.06
- PTGX 0.11
- Stochastic Oscillator
- ORLA 77.08
- PTGX 98.00
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.